ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Guidelines Adopted For Pathology Review

February 22, 1980

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977